Regulatory Blog

I still remember sitting in the back of my chemistry class, flipping through massive textbooks just to compare atomic weights or understand a single element. A single question often meant turning dozens of pages. It was slow, and honestly, it sometimes took the excitement out of learning. Fast forward to today, and learning science has completely transformed. Instead of digging through hundreds of pages, we can now explore information instantly with interactive tools. That’s

Artificial Intelligence (AI) is no longer a future concept in pharmaceutical research—it is already influencing how drugs and biological products are discovered, developed, manufactured, and monitored throughout their lifecycle. However, when AI outputs are used to support regulatory decisions , questions of trust, transparency, and accountability become critical. Recognising this, global regulators have begun defining expectations for the responsible use of AI in drug devel

Staying compliant in the life sciences industry has never been more complex. Regulatory changes move faster than ever, global markets evolve continuously, and expectations from agencies keep rising. In this environment, regulatory intelligence is no longer a luxury. It is a core operational pillar. For my 1000th post on Regulatory Affairs News, I’m sharing a full breakdown of the latest regulatory intelligence sources, tools, databases, and best practices . I’m also attachin

On 18 July 2025, the European Commission published detailed Guidelines on the scope of the obligations for providers of general-purpose...

In a world where artificial intelligence (AI) is moving rapidly from theory to practice, regulators are tasked with keeping pace—not only...

What if the agonizing wait for drug approvals could be slashed from days to minutes? Imagine a future where breakthrough therapies reach...

The U.S. Food and Drug Administration (FDA) has marked a significant milestone in its digital transformation journey by announcing the...

The field of pharmacovigilance (PV) —the science of detecting, assessing, understanding, and preventing adverse effects or any other...

In the evolving landscape of medicines regulation, data and artificial intelligence (AI) have become pivotal tools to enhance public and...

The world of pharma and life sciences is abuzz with a major announcement: Veeva Systems has just unveiled Veeva AI , a groundbreaking...

The European Medicines Agency (EMA) has unveiled a comprehensive Artificial Intelligence (AI) Work Plan  to guide the integration of AI...

The U.S. Food and Drug Administration (FDA) released a draft guidance earlier today (07 January, 2025) outlining " Considerations for...

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has launched (4th December 2024) a groundbreaking pilot scheme "...

The advancement of Artificial Intelligence (AI)  is transforming many industries, and the pharmaceutical and regulatory sectors are no...

Artificial Intelligence (AI) is a broad term that encompasses many different things and is a kind of intelligence that is created by a...

According to the U.S. Food and Drug Administration (FDA), the purpose of a "CAPA program is to collect information, analyze information,...

Interviews are tough! At least people like me, have always struggled to answer in interviews. Whatever or How much ever we prepare, we...

Hi Guys! You have been my supporters and wellwishers from the day I published this website. As you have been supportive of me from day...

I created a Visual Aid to access #175+ countries HEALTH AGENCY WEBSITE in a Single Touch (1 Click). Just click the link HERE to the...